Record Profit & Doubled Guidance — But Can Margins Hold?

In isolation, the quarter was exceptional: record revenue, profit, and margins delivered in Q1 — with management confidence to raise FY27 growth guidance from 20–25% to 40%. Yet the stock fell 11% by day 5 post-result. This gap — pristine fundamentals vs. heavy selling — is the story. The street's skepticism centers on one question: can HFCL sustain 23%+ EBITDA margins as preform costs rise, defense orders remain unproven, and the data center ramp requires ₹165 Cr of capex?

HFCL is not overstating the breadth. Revenue of ₹1,915 Cr was driven by three simultaneous tailwinds: optical fiber cable (the bulk, ₹16k Cr order book), data center connectivity (emerging at ₹100 Cr Q1, targeting ₹800 Cr FY27), and defense (₹300 Cr current orders, ₹2.2k Cr export visibility post-acquisition). The order book is genuine; the margin of 23.25% EBITDA reflects a favorable mix of high-margin, long-term contracts. Management had every reason to underpromise on FY27 and did not — it raised guidance to 40%, implying ~₹7,420 Cr full-year revenue (vs. ₹5,390 Cr FY26). That's a step-change, not an extrapolation.

But the order book alone does not guarantee the margin. Optical fiber cable is 65–70% preform cost. Preform suppliers have been raising prices as demand outstrips global capacity; management claims that long-term contracts with yearly reset clauses and in-house preform manufacturing (₹580 Cr capex, 30% cost save target) will hedge the risk. This is plausible, but unquantified. When pressed on whether customer price hikes could offset supplier inflation, management said 'multiple offsets' — data center mix (higher margins), better product mix, in-house manufacturing — but gave no timeline or quantification. That vagueness is where the street's doubt lives.

FY27 guidance was raised from 20–25% to 40% growth, backed by order inflows (₹26.6k Cr all-time high, up from ~₹21.2k Cr prior guidance). Management already delivered a ₹23.25% EBITDA margin (vs. 20% aspiration for full year), signaling that margin expansion is structural, not one-time. The call unlocked three catalysts: Army warranty project (₹170 Cr AMC expected Q2), aerospace acquisition (₹2.2k Cr orders, Q4 FY26 calendar close), and optical fiber capacity ramp (28→34M km by Dec 2026). Defense now has a ₹500 Cr FY27 aspiration and ₹3k–5k Cr for FY28–29.

Post-result price action tells the story. The stock opened day 1 down 5% (normal, pre-release short covering), but by day 3 was down 11.64%, and by day 5 down 11.17%. The decline accelerated through day 3, then stabilized, suggesting the market repriced 40% guidance as risky after the call. No quick reversal; the stock recovered only slightly by Jul 31 (to ₹193.92, still down 10.96% from pre-result ₹217.90). This is not panic selling, but a decisive repricing: the order book is real, but the margin and defense execution are now priced as contingent, not assured.

Valuation context: Stock is down 15.45% from its all-time high of ₹229.36, but up 224% from its 52-week low. It's trading below SMA20 (₹209.33) and SMA50 (₹196.54), but well above SMA200 (₹108.79). RSI 38.8 is neutral (not oversold, but declining momentum). Volume is normal. The stock is in a measured downtrend post-result, not a panic capitulation — consistent with the 'Hold' verdict.

Institutional flows are negative: FII holdings declined 0.4 percentage points (to 7.08%), and DII declined 0.49 percentage points (to 8.58%), while promoters held flat. This suggests institutions are trimming exposure ahead of FY27 execution milestones or concerned about margin/defense risk. Bulk deals from late June show a mix of buys and sells around ₹113–114 (pre-result), with no obvious insider selling at the highs — neutral-to-bullish signal, but insufficient new buying near current levels (₹193) is notable.